The Office of the U.S. Trade Representative launched a Section 301 investigation on Brazilian policies that discriminate against American firms, naming these issues:
Former top trade negotiator Wendy Cutler, who, as a career employee in the Office of the U.S. Trade Representative led on the South Korea-U.S. free trade agreement and the Trans-Pacific Partnership, said that South Korea can't make concessions to avoid 25% tariffs on its exports if the 25% Section 232 tariffs on autos and 50% tariffs on steel go unchanged in the deal.
President Donald Trump, after returning from a political event in Pennsylvania the evening of July 15, told reporters that Section 232 tariffs on pharmaceuticals will start "probably at the end of the month, and we're going to start off with a low tariff and give the pharmaceutical companies a year or so to build, and then we're going to make it a very high tariff, because we gotta move them here."
The U.S. Chamber of Commerce and the American Chamber of Commerce in Brazil both are urging the Brazilian government and the U.S. government to negotiate so that 50% tariffs on Brazilian goods don't come to pass.
A Federal Maritime Commission small claims officer on July 14 dismissed a demurrage-related complaint against ZIM Integrated Shipping Services, saying Oregon-based exporter Bridgewell Agribusiness had no contractual relationship with the Israeli ocean carrier.
The Federal Maritime Commission this week updated its record of cases and decisions related to shipping violations “that may be significant or establish legal precedent.” The 807-page document now incorporates decisions that took place from January 2024 through December 2024.
The International Trade Commission published notices in the July 15 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register July 15 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department made preliminary affirmative antidumping duty determinations that imports of float glass from China (A-570-188) and Malaysia (A-557-832) are being sold in the U.S. at less than fair value. The agency will impose AD cash deposit requirements retroactively on one exporter of subject merchandise from Malaysia -- NSG (Malaysian Sheet Glass) -- beginning April 16, 2025. For Chinese exporters and all other Malaysian exporters, suspension of liquidation and cash deposit requirements take effect July 15, 2025.
On July 14, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: